Symrise (FRA:SY1) has been given a €67.00 ($82.72) target price by equities research analysts at equinet in a note issued to investors on Wednesday. The firm presently has a “neutral” rating on the stock. equinet’s price objective would indicate a potential upside of 8.06% from the stock’s previous close.
A number of other research analysts also recently weighed in on SY1. Berenberg Bank set a €67.00 ($82.72) target price on Symrise and gave the company a “neutral” rating in a report on Thursday, November 16th. Kepler Capital Markets set a €65.50 ($80.86) target price on Symrise and gave the company a “neutral” rating in a report on Tuesday, November 28th. Societe Generale set a €85.00 ($104.94) target price on Symrise and gave the company a “buy” rating in a report on Tuesday, December 5th. UBS Group set a €75.00 ($92.59) target price on Symrise and gave the company a “neutral” rating in a report on Thursday, December 7th. Finally, Nord/LB set a €70.00 ($86.42) price target on Symrise and gave the stock a “neutral” rating in a research report on Friday, December 8th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and six have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of €68.42 ($84.47).
Symrise (SY1) traded down €4.54 ($5.60) during mid-day trading on Wednesday, reaching €62.00 ($76.54). The company’s stock had a trading volume of 1,598 shares. Symrise has a 52 week low of €56.96 ($70.32) and a 52 week high of €73.48 ($90.72). The company has a market capitalization of $7,910.00 and a P/E ratio of 30.85.
Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.
Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.